The estimated Net Worth of Garrett Sato is at least $750 dollars as of 13 December 2018. Mr. Sato owns over 5,000 units of Biolase Inc stock worth over $750 and over the last 7 years he sold BIOL stock worth over $0. In addition, he makes $0 as Independent Director at Biolase Inc.
Sign up
Mr. Sato BIOL stock SEC Form 4 insiders trading
Garrett has made over 3 trades of the Biolase Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of BIOL stock worth $5,350 on 13 December 2018.
The largest trade he's ever made was buying 5,000 units of Biolase Inc stock on 13 December 2018 worth over $5,350. On average, Garrett trades about 1,667 units every 14 days since 2018. As of 13 December 2018 he still owns at least 15,000 units of Biolase Inc stock.
You can see the complete history of Mr. Sato stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Garrett Sato biography
Garrett Sato serves as Independent Director of the Company. Mr. Sato is an Executive Partner at Inverness Graham Investments, a private investment firm that acquires manufacturing, technology and services companies, a position he has held since June 2013. Since October 2015, Mr. Sato has served as a Consultant to Vita North America, a dental products company focused on shade technology, and since May 2017, Mr. Sato has served as an Executive Advisor to Orchestrate 3D, a company that uses 3D technology to provide dental products and services. From December 2013 to February 2016, Mr. Sato was the Chairman and Chief Executive Officer of Danville Materials LLC, a manufacturer of restorative consumables and small equipment for the dental market, which was owned by Inverness Graham Investments from January 2014 to February 2016. From June 2011 to December 2013, Mr. Sato served as an advisor or consultant for several companies in the dental products industry: Isolite Corporation, Shofu Dental Corporation, Clinical Research Dental and Mani, Inc. From October 2009 to June 2011, Mr. Sato served as the Executive Vice President of Discus Dental L.L.C., a manufacturing, distributing and marketing company focused on tooth whitening products. From July 2004 to September 2009, Mr. Sato was the President of Orascoptic and its Surgical Acuity brand, a provider of vision solutions for dental professionals, and from August 1996 to March 2006, he served as Vice President, International, of Kerr Corporation, a provider of dental supplies. Mr. Sato also serves or has served as a director of a number of private companies. Mr. Sato holds a Bachelor of Science degree in Marketing from California State University, Long Beach. Mr. Sato brings to our Board extensive management and operational experience, particularly in the dental industry.
How old is Garrett Sato?
Garrett Sato is 59, he's been the Independent Director of Biolase Inc since 2018. There are 6 older and 8 younger executives at Biolase Inc. The oldest executive at Biolase Inc is Richard R. Whipp, 69, who is the VP of Operations.
What's Garrett Sato's mailing address?
Garrett's mailing address filed with the SEC is 27042 TOWNE CENTRE DR., SUITE 270, FOOTHILL RANCH, CA, 92610.
Insiders trading at Biolase Inc
Over the last 12 years, insiders at Biolase Inc have traded over $9,258,543 worth of Biolase Inc stock and bought 25,366,011 units worth $28,515,794 . The most active insiders traders include Jack W Schuler, Larry Noracle Partners Lp O..., and Larry N Feinberg. On average, Biolase Inc executives and independent directors trade stock every 57 days with the average trade being worth of $31,910. The most recent stock trade was executed by Jonathan T Md Lord on 7 December 2022, trading 3,537 units of BIOL stock currently worth $2,653.
What does Biolase Inc do?
biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. biolase’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. biolase is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.
What does Biolase Inc's logo look like?
Complete history of Mr. Sato stock trades at Biolase Inc
Biolase Inc executives and stock owners
Biolase Inc executives and other stock owners filed with the SEC include:
-
Todd Norbe,
President, Chief Executive Officer, Director -
John Beaver,
Chief Financial Officer, Executive Vice President -
John R. Beaver,
Pres, CEO & Director -
Jonathan Lord,
Independent Chairman of the Board -
Michael Polyviou,
IR Contact Officer -
Elaine Wagner,
Independent Director -
Garrett Sato,
Independent Director -
Jess Roper,
Independent Director -
Richard Lanman,
Independent Director -
Michael DiTolla,
Independent Director -
Richard Whipp,
Vice President - Operations -
Richard R. Whipp,
VP of Operations -
Jennifer Bright,
VP of Fin. -
David Rodriguez,
Director of Education & Events -
Brendan O'Connell,
VP of Fin. and Corp. Controller -
Michael C. Carroll,
Corp. Sec. -
Holger Arens,
VP & MD of Europe, the Middle East & Africa -
Dr. Samuel B. Low,
Chief Dental Officer and VP of Dental & Clinical Affairs -
Matthew Wilson,
VP of HR -
Daniel Merkin,
National Sales Director -
Larry Noracle Partners Lp O...,
-
David C Dreyer,
SVP / Chief Financial Officer -
Jack W Jack W. Schuler Livi...,
-
Mark Joseph Nelson,
SVP & Chief Financial Officer -
Paul N Clark,
Director -
James R Talevich,
Director -
Frederic H Moll,
Director -
Harold C Jr. Flynn,
President and CEO -
Jack W Schuler,
-
Larry Noracle Partners Lp O...,
-
Carol Gomez Dds Summerhays,
Director -
Martha J. Dds, Ph D Somerman,
Director -
Larry Noracle Partners Lp F...,
-
Larry N Feinberg,
10% owner -
Frederick D. Furry,
Chief Financial Officer -
Jeffrey M Nugent,
Acting Chief Executive Officer -
Samuel Bernard Low,
Director -
Erin S. Enright,
Director -
Alexander K. Arrow,
President and COO -
Norman J. Nemoy,
Director -
Gregory Lichtwardt,
Director -
Federico Pignatelli,
Chairman and CEO -
Kenneth P. Yale,
Director -
Kathleen T O Loughlin,
Director -
Steven Sandor,
Chief Operating Officer -
Jennifer Bright,
Chief Financial Officer -
Education Foundation Schuler,